作者
Michael J Hendrickson, Vardhmaan Jain, Kirtipal Bhatia, Christopher Chew, Sameer Arora, Joseph S Rossi, Pedro Villablanca, Navin Kapur, Aditya Joshi, Arieh Fox, Kiran Mahmood, Edo Y Birati, Mark J Ricciardi, Arman Qamar
发表日期
2022/7/1
期刊
Cardiovascular Revascularization Medicine
卷号
40
页码范围
86
出版商
Elsevier
简介
Background: Secondary mechanical circulatory support (MCS) devices such as intra-aortic balloon pump (IABP) and Impella are postulated to counteract left ventricular afterload from veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Trial and outcomes data to support this practice are limited.
Methods: Hospitalizations for cardiogenic shock and VA-ECMO from 2016 to 2018 were identified from the National Inpatient Sample. Poisson regression evaluated trends in utilization semiannually. Multivariable logistic and general linear regression evaluated associations of second MCS device use with in-hospital mortality, discharge disposition, and length of stay.
Results: Overall, 460,040 hospitalizations (unweighted 92,008) were identified; 12,035 (3%) underwent VA-ECMO, of which 3,115 (26%) also received IABP and 1,880 (16%) Impella. Utilization of Impella with VA-ECMO substantially increased from …
学术搜索中的文章
MJ Hendrickson, V Jain, K Bhatia, C Chew, S Arora… - Cardiovascular Revascularization Medicine, 2022